Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization

Blood

Volumn 89, Issue 5, 1997, Pages 1678-1685

  Mathew, Prasad ^b   Sanger, Warren G ^b   Weisenburger, Dennis D ^b   Valentine, Marcus ^b   Valentine, Virginia ^b   Pickering, Diane ^b   Higgins, Chris ^b   Hess, Michelle ^b   Cui, Xiaoli ^b   Srivastava, Deo Kumar ^b   Morris, Stephan W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ARTICLE; CELL SURVIVAL; CHROMOSOME 5; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTERPHASE; LARGE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0031018495     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1678     Document Type: Article

References (48)

1. Stein H, Dallenbach F: Diffuse large cell lymphomas of B and T cell type, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Wiliams & Wilkins, 1992, p 675
2. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Tanaka H, Sasaki M, Suchi T, Kikuta A, Wakaso H, Hojo H, Mizutani S: A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1989
3. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW: The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3:866, 1989
4. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW: Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 14:305, 1990
5. Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol 71:31, 1989
6. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristoffersson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet VJ, Warnke R: CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
7. Shikano T, Ishikawa Y, Naito Y, Kobayashi R, Nakadate H, Hatae Y, Takeda T: Cytogenetic characteristics of childhood non-Hodgkin lymphoma. Cancer 70:714, 1992
8. Sandlund JT, Pui CH, Roberts M, Morris SW, Mahmoud H, Berard CW, Hutchison RE, Crist WM, Rafferty M, Raimondi SC: Clinicopathologic features and treatment outcome of children with large cell lymphoma and the t(2;5)(p23;q35). Blood 84:2467, 1994
9. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger DD, Kossakowska AE, Thorner P, Lorenzanz A, Ladanyi M, Morris SW: Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416, 1995
10. Kadin ME: Ki-1/CD30+ (anaplastic) large-cell lymphoma: Maturation of a Clinicopathologic entity with prospects of effective therapy (editorial). J Clin Oncol 12:884, 1994
11. Kadin ME: Primary Ki-1-positive anaplastic large cell lymphoma: A district Clinicopathologic entity. Ann Oncol 5:S25, 1994
12. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a Subset of normal lymphoid cells. Nature 299:65, 1982
13. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, et al: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
14. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421, 1992
15. Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gluniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gills S, Din WS, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349, 1993
16. Offit K, Ladanyi M, Gangi MD, Ebrahim SA, Filippa D, Chaganti RS: Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 4:625, 1990
17. Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS: Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 9:539, 1991
18. Eden GJ, Evans AE: Anaplastic large cell lymphoma in childhood. Med Pediatr Oncol 21:665, 1993
19. Shulman LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos G, Tung N, Kadin M: Primary Ki-1 anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 11:937, 1993
20. Vecchi V, Burnelli R, Pileri S, Rosito P, Sabattini E, Civino A, Pericoli R, Paolucci G: Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood. Med Pediatr Oncol 21:402, 1993
21. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H, Riehm H: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899, 1994
22. Romaguera JE, Manning JT, Todriguez TJ, Brooks TE, Pugh WC, Orgonez NG, Goodacre AM, Cabanillas F: Long term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma. Ann Oncol 5:317, 1994
23. Sandlund JT, Pui CH, Santana VM, Mahmoud H, Roberts WM, Morris S, Raimondi S, Ribeiro R, Crist WM, Lin JS, Mao L, Berard CW, Hutchison RE: Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma. J Clin Oncol 12:895, 1994
24. Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T, Mori S: Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: A distinct clinicopathologic entity. Blood 86:1954, 1995
25. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
26. Downing JR, Morris SW: The non-Hodgkin's lymphoma-associated t(2;5) translocation: Molecular biology and clinical features. Clin Immunol Newsletter 14:44, 1994
27. Schmidt-Zachmann MS, Franke WW: DNA cloning and amino acid sequence determination of a major constituent protein of mammalian nucleoli, Correspondence of the nucleoplasmin-related protein NO38 to mammalian protein B23. Chromosoma 96:417, 1988
28. Borer RA, Lehner CF, Eppenberger HM, Nigg EA: Major J nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379. 1989
29. Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK: Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28:1033, 1989
30. Dumbar TS, Gentry GA, Olson MOJ: Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 28:9495, 1993
31. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S: Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9:1567, 1994
32. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648, 1994
33. Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R, Cleary ML: Lack of involvement of the c-fms and Nmyc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73:2155, 1989
34. Koeffler HP: Human acute myeloid leukemia lines: Models of leukemogenesis. Semin Hematol 23:223, 1986
35. Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC: Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood 86:3517, 1995
36. Conover WJ: Some methods based on ranks, in Practical Nonparametric Statistics. New York, NY, Wiley, 1980
37. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D: Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science 250:559, 1990
38. Biegel JA, Nycum LM, Valentine V, Barr FG, Shapiro DN: Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization. Genes Chromosom Cancer 12:186, 1995
39. Leoncini L, Del Vecchio MT, Kraft R, Megha T, Barbini P, Cevenini G, Poggi S, Pileri S, Tosi P, Cottier H: Hodgkin's disease and CD30-positive anaplastic large cell lymphomas-a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol 137:1047, 1990
40. Ladanyi M, Cavalchire G, Morris SW, Downing J, Filippa DA: Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease (published erratum appears in Am J Pathol 146:546, 1995) Am J Pathol 145:1296, 1994
41. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
42. Weiss LM, Lopategui JR, Sun LH, Kamel OW, Koo CH, Glackin C: Absence of the t(2;5) in Hodgkin's disease. Blood 85:2845, 1995
43. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC: Large-cell anaplastic lymphoma-specific translocation (t[2;5J [p23;q35]) in Hodgkin's disease: Indication of a common pathogenesis? (see comments). Lancet 345:87, 1995
44. Herbst H, Anagnostopoulos J, Heinze B, Durkop H, Hummel M, Stein H: ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 86:1694, 1995
45. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M: Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 86:2321, 1995
46. Lamant L, Meggetto F, Al Saati T, Brugieres L, de Paillerets B, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 87:284, 1996
47. Thompson CT, LeBoit PE, Nederlof PM, Gray JW: Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Am J Pathol 144:237, 1994
48. Kuchinka BD, Kalousek DK, Lomax BL, Harrison KJ, Barrett IJ: Interphase cytogenetic analysis of single cell suspensions prepared from previously formalin-fixed and paraffin-embedded tissues. Mod Pathol 8:183, 1995